BE901980A - Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments.

Info

Publication number
BE901980A
BE901980A BE1/011217A BE1011217A BE901980A BE 901980 A BE901980 A BE 901980A BE 1/011217 A BE1/011217 A BE 1/011217A BE 1011217 A BE1011217 A BE 1011217A BE 901980 A BE901980 A BE 901980A
Authority
BE
Belgium
Prior art keywords
medicaments
preparation
cyclosporin derivatives
novel cyclosporin
novel
Prior art date
Application number
BE1/011217A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE901980A publication Critical patent/BE901980A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE1/011217A 1984-03-23 1985-03-21 Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments. BE901980A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (1)

Publication Number Publication Date
BE901980A true BE901980A (fr) 1985-09-23

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011217A BE901980A (fr) 1984-03-23 1985-03-21 Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments.

Country Status (24)

Country Link
US (1) US4639434A (enEXAMPLES)
JP (1) JPH08838B2 (enEXAMPLES)
AT (1) AT388737B (enEXAMPLES)
BE (1) BE901980A (enEXAMPLES)
CA (1) CA1247546A (enEXAMPLES)
CH (1) CH667274A5 (enEXAMPLES)
CS (1) CS249542B2 (enEXAMPLES)
DE (1) DE3509809A1 (enEXAMPLES)
DK (1) DK128285A (enEXAMPLES)
ES (1) ES8702926A1 (enEXAMPLES)
FI (1) FI851120L (enEXAMPLES)
FR (1) FR2561651B1 (enEXAMPLES)
GB (1) GB2155936B (enEXAMPLES)
GR (1) GR850716B (enEXAMPLES)
HU (1) HU200786B (enEXAMPLES)
IL (1) IL74681A (enEXAMPLES)
IT (1) IT1199962B (enEXAMPLES)
LU (1) LU85819A1 (enEXAMPLES)
NL (1) NL8500828A (enEXAMPLES)
NO (1) NO851160L (enEXAMPLES)
NZ (1) NZ211526A (enEXAMPLES)
PH (2) PH21868A (enEXAMPLES)
PT (1) PT80149B (enEXAMPLES)
SE (1) SE461334B (enEXAMPLES)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587342T2 (de) 1984-10-04 1993-12-02 Sandoz Ag Cyclosporine.
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
DE3888357T2 (de) * 1987-06-22 1994-09-15 Merck & Co Inc Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
ATE109970T1 (de) * 1987-09-03 1994-09-15 Univ Georgia Res Found Cyclosporin-augenmittel.
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (enEXAMPLES) * 1988-05-13 1991-12-31 Sandoz Ag
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
SK278808B6 (sk) * 1990-11-02 1998-03-04 Novartis Ag Cyklosporíny, ich použitie pri príprave liečiva na
EP0674178B1 (en) 1990-11-20 2002-08-28 Dade Behring Marburg GmbH Cyclosporin immunoassay
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
RU2170741C2 (ru) * 1996-08-16 2001-07-20 Новартис Аг Способ получения циклоспорина
EP0991660B8 (en) 1997-10-08 2006-04-05 Isotechnika,Inc. DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US5990274A (en) * 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
MXPA04003625A (es) * 2001-10-19 2004-12-02 Sotechnika Inc Sintesis de analogos de ciclosporina.
WO2003032949A1 (en) * 2001-10-19 2003-04-24 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
EP1603512A2 (en) * 2003-03-17 2005-12-14 Albany Molecular Research, Inc. Novel cyclosporins
WO2006039163A2 (en) * 2004-09-29 2006-04-13 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
WO2006039164A2 (en) * 2004-09-29 2006-04-13 Amr Technology, Inc. Novel cyclosporin analogues and their pharmaceutical uses
US7361636B2 (en) * 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7576057B2 (en) 2006-11-20 2009-08-18 Scynexis, Inc. Cyclic peptides
ES2705750T3 (es) 2010-12-15 2019-03-26 Contravir Pharmaceuticals Inc Moléculas análogas de la ciclosporina modificadas en los aminoácidos 1 y 3
PT2683406T (pt) 2011-03-11 2019-07-08 Beth Israel Deaconess Medical Ct Inc Anticorpos anti-cd40 e utilização dos mesmos
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
JP6976931B2 (ja) 2015-09-04 2021-12-08 プリマトープ・セラピューティクス・インコーポレイテッド ヒト化抗cd40抗体及びその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056782B1 (en) * 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine

Also Published As

Publication number Publication date
JPH08838B2 (ja) 1996-01-10
SE8501392L (sv) 1985-09-24
FI851120A0 (fi) 1985-03-20
IL74681A0 (en) 1985-06-30
SE8501392D0 (sv) 1985-03-21
GB8507270D0 (en) 1985-04-24
IT8547852A0 (it) 1985-03-22
NL8500828A (nl) 1985-10-16
GB2155936A (en) 1985-10-02
LU85819A1 (fr) 1985-12-12
IT1199962B (it) 1989-01-05
PT80149B (en) 1987-03-23
PH21868A (en) 1988-03-25
PT80149A (en) 1985-04-01
AT388737B (de) 1989-08-25
CS249542B2 (en) 1987-03-12
DE3509809A1 (de) 1986-01-09
CH667274A5 (de) 1988-09-30
PH23357A (en) 1989-07-14
FR2561651A1 (fr) 1985-09-27
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
FI851120A7 (fi) 1985-09-24
NZ211526A (en) 1988-08-30
SE461334B (sv) 1990-02-05
GB2155936B (en) 1987-09-16
ES8702926A1 (es) 1987-01-16
JPS60215700A (ja) 1985-10-29
IT8547852A1 (it) 1986-09-22
DK128285A (da) 1985-09-24
US4639434A (en) 1987-01-27
IL74681A (en) 1989-09-10
HU200786B (en) 1990-08-28
GR850716B (enEXAMPLES) 1985-07-19
NO851160L (no) 1985-09-24
FI851120L (fi) 1985-09-24
DK128285D0 (da) 1985-03-21
FR2561651B1 (fr) 1990-03-09
ES541465A0 (es) 1987-01-16
HUT38370A (en) 1986-05-28

Similar Documents

Publication Publication Date Title
BE901980A (fr) Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments.
AU588860B2 (en) Improvements in or relating to organic compounds
FR2432503A1 (fr) Nouveaux nonapeptides, leur procede de preparation et leur application comme medicaments
BE905954A (fr) Preparation pulverisable de dihydropyridine, son procede de production et son utilisation pharmaceutique.
FR2607493B1 (fr) Nouveaux composes pharmacologiquement actifs, leurs procedes de preparation et les compositions en contenant
HUP9900338A2 (hu) Sokfunkciós enzim
IT8520769A0 (it) Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
CA2331870A1 (fr) Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR930006027A (ko) 엔케팔리나제 및 안지오텐신 전환 효소(ace)의 억제제로서 유용한 2-치환 인단-2-메르캅토아세틸아미드 유도체
BE1002213A5 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
BE904368A (fr) Nouveaux derives de pyridylmethoxy- et methylmercaptoanilines, utiles notamment comme antiasthmatiques, leur fabrication et medicaments les contenant.
IE861997L (en) Zwitterionic bicyclic compounds
BE901456A (fr) Nouvelles 8 alpha-acylaminoergolines, leur preparation et leur utilisation comme medicaments.
FR2391191A1 (fr) Nouveaux composes polypeptidiques, lyeptidiques, leur preparation et leur application comme medicaments
FR2608159B1 (fr) Nouveaux derives de l'acide furannuronique, leur preparation et leur utilisation comme medicaments
EP0272174A3 (fr) Préparations d'adenyl cyclase purifiées, procédé d'obtention de ces préparations et leurs applications biologiques
ATE37369T1 (de) Eine thiazinverbindung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
IE872239L (en) Pyridopyrimidinediones and quinazolines
CA2330351A1 (fr) Nouvelles urees lineaires ou cycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA20926A1 (fr) Composes heterocycliques azotes nouveaux, compositions les contenant, leur preparation et leur application pour reduire la perte d'humidite de plantes et pour accroitre le rendement de cultures.
FR2692899B1 (fr) Nouveaux dérivés peptidiques actifs dans les processus d'adhésion cellulaire, leur procédé de préparation et les compositions pharmaceutiques qui les renferment.
BE899526A (fr) Nouveaux derives d'acylaminophenols, leur preparation et leur utilisation comme medicaments.
BE1003219A3 (fr) NOUVEAUX DERIVES DE L'OCTAHYDROBENZO[g]QUINOLEINE, LEUR PREPARATION ET LEUR UTILISATION COMME MEDICAMENTS.
FR2593501B1 (fr) Nouveaux derives bis (r-oxyimino)-5,7 dihydro-6,7 (5h) dibenzo (a,c) cycloheptene, leurs procedes de preparation et leur application comme medicaments
FR2439181A1 (fr) Peptides apparentes a la somatostatine et leur utilisation therapeutique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: NOVARTIS A.G.

Effective date: 19990331